Search - tctmd.com

Displaying 601 - 620 of 1606

Sort: Relevancy | Date

News Conference News TCT 2017

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

Yael L. Maxwell

November 01, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day One

Shelley Wood

October 30, 2017

News Conference News TCT 2017

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Todd Neale

October 30, 2017

News Daily News

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

Todd Neale

October 23, 2017

News Daily News

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Yael L. Maxwell

October 20, 2017

News Daily News

Lower Limb Revascularizations Increasing in PAD Patients on Dialysis

L.A. McKeown

October 18, 2017

News Daily News

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Shelley Wood

October 16, 2017

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Shelley Wood

October 10, 2017

News Daily News

High-Sensitivity Troponin Tests Still Useful in Patients With Renal Dysfunction and Suspected ACS, With Caveats

Yael L. Maxwell

October 06, 2017

News Conference News PCR London Valves 2017

As Percutaneous Mitral Valve Techniques Advance, Questions Turn to Combinations, Staging

Shelley Wood

September 26, 2017

News Daily News

Frail Patients Benefit From MitraClip, With Gains in Function and Quality of Life

Michael O'Riordan

September 18, 2017

News Conference News VIVA 2017

EVAR Outcomes Equivalent Between Men and Women, Registries Show

L.A. McKeown

September 14, 2017

News Conference News VIVA 2017

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

L.A. McKeown

September 13, 2017

News Conference News VIVA 2017

Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients

L.A. McKeown

September 11, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2017

Caitlin E. Cox

August 31, 2017

News Conference News ESC 2017

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

Michael O'Riordan

August 31, 2017

News Industry News

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

August 30, 2017

News Conference News ESC 2017

Under Pressure: PRECISION Substudy Shows Adverse BP Effects of Ibuprofen

L.A. McKeown

August 30, 2017

News Conference News ESC 2017

Renal Denervation: Proof-of-Concept Study Gives Fresh Jolt to Fizzled Field

Todd Neale

August 28, 2017

News Daily News

Smoking Cessation Drugs: Missed Opportunity for Patients Hospitalized for CHD

Caitlin E. Cox

August 23, 2017

Advertisement

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

Live From Denver: TCT 2017, Day One

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Lower Limb Revascularizations Increasing in PAD Patients on Dialysis

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

High-Sensitivity Troponin Tests Still Useful in Patients With Renal Dysfunction and Suspected ACS, With Caveats

As Percutaneous Mitral Valve Techniques Advance, Questions Turn to Combinations, Staging

Frail Patients Benefit From MitraClip, With Gains in Function and Quality of Life

EVAR Outcomes Equivalent Between Men and Women, Registries Show

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients

TCTMD’s Top 10 Most Popular Stories for August 2017

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

Under Pressure: PRECISION Substudy Shows Adverse BP Effects of Ibuprofen

Renal Denervation: Proof-of-Concept Study Gives Fresh Jolt to Fizzled Field

Smoking Cessation Drugs: Missed Opportunity for Patients Hospitalized for CHD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content